The Asia Pacific Minimal Residual Disease Testing Market would witness market growth of 15.3% CAGR during the forecast period (2022-2028).
Various institutions and organizations are researching the predictive significance of MRD tests in adult patients. Therefore, the outcomes of MRD investigations can be utilized to decide on the type and length of treatment, as well as to calculate the ideal window of time for hematopoietic stem cell transplantation (HSCT).
In addition, the discovery of new leukemia biomarkers and the application of increasingly accurate assays would make routine MRD monitoring even more manageable. This would further raise the significance of MRD tests and will contribute to a better understanding of the cellular and biological characteristics of leukemic cells that withstand chemotherapy in vivo.
The rising incidence of cancer worldwide and the higher acceptance of cancer therapies in developing nations are boosting the demand for MRD tests. The simultaneous shifts in healthcare from diagnosis of disease to early diagnosis or risk assessment and the expanding biomarkers' use in drug development are all contributing factors to the market's expansion.
Cancer is one of the leading causes of death in Asian nations. According to the National Cancer Center, three types of blood cancers, multiple lymphomas, malignant myelomas, and leukemia, also make up a portion of all cancers in Japan. The prevalence of cancer has sharply increased in recent years, and it is predicted that this trend will continue during the forecast period.
The China market dominated the Asia Pacific Minimal Residual Disease Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $211.1 million by 2028.The Japan market is experiencing a CAGR of 14.6% during (2022 - 2028). Additionally, The India market would display a CAGR of 16.1% during (2022 - 2028).
Based on Application, the market is segmented into Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors and Others. Based on End User, the market is segmented into Hospitals & Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes and Others. Based on Technology, the market is segmented into Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Flow Cytometry and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Minimal Residual Disease Testing Market is Projected to reach USD 2.7 Billion by 2028, at a CAGR of 14.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Rad Laboratories, Inc., Guardant Health, Inc., Invitae Corporation (ArcherDX, Inc.), Bio-Techne Corporation, F. Hoffmann-La Roche Ltd., ICON plc (MolecularMD Corporation), Natera, Inc., Sysmex Corporation, Laboratory Corporation of America Holdings, and Invivoscribe, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Hematological Malignancies
- Leukemia
- Lymphoma
- Solid Tumors
- Others
By End User
- Hospitals & Specialty Clinics
- Diagnostic Laboratories
- Academic & Research Institutes
- Others
By Technology
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing (NGS)
- Flow Cytometry
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Bio-Rad Laboratories, Inc.
- Guardant Health, Inc.
- Invitae Corporation (ArcherDX, Inc.)
- Bio-Techne Corporation
- F.Hoffmann-La Roche Ltd.
- ICON plc (MolecularMD Corporation)
- Natera, Inc.
- Sysmex Corporation
- Laboratory Corporation of America Holdings
- Invivoscribe, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Minimal Residual Disease Testing Market, by Application
1.4.2 Asia Pacific Minimal Residual Disease Testing Market, by End User
1.4.3 Asia Pacific Minimal Residual Disease Testing Market, by Technology
1.4.4 Asia Pacific Minimal Residual Disease Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Minimal Residual Disease Testing Market by Application
3.1 Asia Pacific Hematological Malignancies Market by Country
3.2 Asia Pacific Leukemia Market by Country
3.3 Asia Pacific Lymphoma Market by Country
3.4 Asia Pacific Solid Tumors Market by Country
3.5 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Minimal Residual Disease Testing Market by End User
4.1 Asia Pacific Hospitals & Specialty Clinics Market by Country
4.2 Asia Pacific Diagnostic Laboratories Market by Country
4.3 Asia Pacific Academic & Research Institutes Market by Country
4.4 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Minimal Residual Disease Testing Market by Technology
5.1 Asia Pacific Polymerase Chain Reaction (PCR) Market by Country
5.2 Asia Pacific Next-Generation Sequencing (NGS) Market by Country
5.3 Asia Pacific Flow Cytometry Market by Country
5.4 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Minimal Residual Disease Testing Market by Country
6.1 China Minimal Residual Disease Testing Market
6.1.1 China Minimal Residual Disease Testing Market by Application
6.1.2 China Minimal Residual Disease Testing Market by End User
6.1.3 China Minimal Residual Disease Testing Market by Technology
6.2 Japan Minimal Residual Disease Testing Market
6.2.1 Japan Minimal Residual Disease Testing Market by Application
6.2.2 Japan Minimal Residual Disease Testing Market by End User
6.2.3 Japan Minimal Residual Disease Testing Market by Technology
6.3 India Minimal Residual Disease Testing Market
6.3.1 India Minimal Residual Disease Testing Market by Application
6.3.2 India Minimal Residual Disease Testing Market by End User
6.3.3 India Minimal Residual Disease Testing Market by Technology
6.4 South Korea Minimal Residual Disease Testing Market
6.4.1 South Korea Minimal Residual Disease Testing Market by Application
6.4.2 South Korea Minimal Residual Disease Testing Market by End User
6.4.3 South Korea Minimal Residual Disease Testing Market by Technology
6.5 Singapore Minimal Residual Disease Testing Market
6.5.1 Singapore Minimal Residual Disease Testing Market by Application
6.5.2 Singapore Minimal Residual Disease Testing Market by End User
6.5.3 Singapore Minimal Residual Disease Testing Market by Technology
6.6 Malaysia Minimal Residual Disease Testing Market
6.6.1 Malaysia Minimal Residual Disease Testing Market by Application
6.6.2 Malaysia Minimal Residual Disease Testing Market by End User
6.6.3 Malaysia Minimal Residual Disease Testing Market by Technology
6.7 Rest of Asia Pacific Minimal Residual Disease Testing Market
6.7.1 Rest of Asia Pacific Minimal Residual Disease Testing Market by Application
6.7.2 Rest of Asia Pacific Minimal Residual Disease Testing Market by End User
6.7.3 Rest of Asia Pacific Minimal Residual Disease Testing Market by Technology
Chapter 7. Company Profiles
7.1 Bio-Rad Laboratories, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.2 Guardant Health, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Product Launches and Product Expansions:
7.3 Invitae Corporation (ArcherDX, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.4 Bio-Techne Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Approvals & Trails:
7.6 ICON plc (MolecularMD Corporation)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Recent strategies and developments:
7.6.4.1 Partnerships, Collaborations, and Agreements:
7.7 Natera Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Sysmex Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.9 Laboratory Corporation of America Holdings
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.9.4 Recent strategies and developments:
7.9.4.1 Partnerships, Collaborations, and Agreements:
7.9.4.2 Product Launches and Product Expansions:
7.10. Invivoscribe, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
TABLE 1 Asia Pacific Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Hematological Malignancies Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Hematological Malignancies Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Leukemia Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Leukemia Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Lymphoma Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Lymphoma Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Solid Tumors Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Solid Tumors Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Hospitals & Specialty Clinics Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Hospitals & Specialty Clinics Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Polymerase Chain Reaction (PCR) Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Polymerase Chain Reaction (PCR) Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Next-Generation Sequencing (NGS) Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Next-Generation Sequencing (NGS) Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Flow Cytometry Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Flow Cytometry Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 35 Asia Pacific Minimal Residual Disease Testing Market by Country, 2018 - 2021, USD Million
TABLE 36 Asia Pacific Minimal Residual Disease Testing Market by Country, 2022 - 2028, USD Million
TABLE 37 China Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 38 China Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 39 China Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 40 China Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 41 China Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 42 China Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 43 China Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 44 China Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 45 Japan Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 46 Japan Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 47 Japan Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 48 Japan Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 49 Japan Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 50 Japan Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 51 Japan Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 52 Japan Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 53 India Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 54 India Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 55 India Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 56 India Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 57 India Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 58 India Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 59 India Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 60 India Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 61 South Korea Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 62 South Korea Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 63 South Korea Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 64 South Korea Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 65 South Korea Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 66 South Korea Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 67 South Korea Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 68 South Korea Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 69 Singapore Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 70 Singapore Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 71 Singapore Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 72 Singapore Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 73 Singapore Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 74 Singapore Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 75 Singapore Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 76 Singapore Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 77 Malaysia Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 78 Malaysia Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 79 Malaysia Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 80 Malaysia Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 81 Malaysia Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 82 Malaysia Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 83 Malaysia Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 84 Malaysia Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 85 Rest of Asia Pacific Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 86 Rest of Asia Pacific Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 87 Rest of Asia Pacific Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 88 Rest of Asia Pacific Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 89 Rest of Asia Pacific Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 90 Rest of Asia Pacific Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 91 Rest of Asia Pacific Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 92 Rest of Asia Pacific Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 93 Key Information – Bio-Rad Laboratories, Inc.
TABLE 94 Key Information – Guardant Health, Inc.
TABLE 95 Key Information – Invitae Corporation
TABLE 96 Key Information – Bio-Techne Corporation
TABLE 97 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 98 Key Information – ICON PLC
TABLE 99 Key Information – Natera Inc.
TABLE 100 key information – Sysmex Corporation
TABLE 101 Key Information – Laboratory Corporation of America holdings
TABLE 102 Key Information – Invivoscribe, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Guardant Health, Inc.
FIG 3 Recent strategies and developments: Laboratory corporation of America Holding